Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy

Immunogenic cell death (ICD), which is triggered by exposure of tumor cells to a limited range of anticancer drugs, radiotherapy, and photodynamic therapy, represents a recent innovation in the revitalized and burgeoning field of oncoimmunnotherapy. ICD results in the cellular redistribution and ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Rapoport, Bernardo L., Anderson, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412296/
https://www.ncbi.nlm.nih.gov/pubmed/30813267
http://dx.doi.org/10.3390/ijms20040959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412296/
https://www.ncbi.nlm.nih.gov/pubmed/30813267
http://dx.doi.org/10.3390/ijms20040959

Ejemplares similares